Abiopharma

News list

📋 Katherine Stueland (Director) plans to sell 16K shares of GeneDx Holdings Corp. (at $63.20 each, total $1.0M) Filed: Apr 29, 2026 | ID: 000022

Full text

News bot April 29, 2026, 10:53 p.m.
📋 Form 144 Filing: Katherine Stueland

Company: GeneDx Holdings Corp.

Filing Date: 2026-04-29

Relationship: Director; Officer
Planned Sale Details:
- Security: Class A Common Stock
- Shares to be Sold: 16,415
- Price per Share: $63.20
- Total Value: $1,037,500.00
- Planned Sale Date: 2026-04-29
- Broker: Morgan Stanley Smith Barney
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39482
- Issuer Contact Phone: 888-729-1206
- Issuer Address: 333 Ludlow St, North Tower, 6th Floor, Stamford, CT, 06902
- Broker Address: 2000 Westchester Avenue, Purchase, NY, 10577
- Shares Outstanding: 29288739.0
- Number of Securities to be Sold: 3
- Number of Past Sales: 5
- Signature: /s/ Katherine Stueland